Skip to main content

We narrowed to 3,492 results for: cre recombinase

Showing: 1021 - 1040 of 3492 results
  1. pHJ17

    Plasmid
    #48356
    Purpose
    Targets beta-Tubulin for Cre-lox mediated knockout in T. brucei, Hygromycin/Gancyclovir selectable
    Depositor
    Insert
    Partial beta-TUB followed by 5' ALD UTR-loxP-SAS-HYG-Ty1-TK-loxP-3' ALD UTR
    Use
    Cre/Lox; Knockout in t. brucei
    Available Since
    Jan. 17, 2014
    Availability
    Academic Institutions and Nonprofits only
  2. pRubiG-T2A-AKT1(S473A)-T2A-Cre

    Plasmid
    #189012
    Purpose
    Retroviral vector with a ubiquitin promoter expressing GFP, human AKT1 ORF with a phosphodeficient mutation at Serine 473, and Cre recombinase, separated by T2A motifs.
    Depositor
    Insert
    AKT1 (AKT1 Human)
    Use
    Retroviral
    Mutation
    Serine at 473 mutated to Alanine
    Available Since
    March 2, 2026
    Availability
    Academic Institutions and Nonprofits only
  3. pRubiG-T2A-AKT1(S473D)-T2A-Cre

    Plasmid
    #189013
    Purpose
    Retroviral vector with a ubiquitin promoter expressing GFP, human AKT1 ORF with a phosphomimetic mutation at Serine 473, and Cre recombinase, separated by T2A motifs.
    Depositor
    Insert
    AKT1 (AKT1 Human)
    Use
    Retroviral
    Mutation
    Serine at 473 mutated to Aspartic Acid
    Available Since
    March 2, 2026
    Availability
    Academic Institutions and Nonprofits only
  4. pHJ18

    Plasmid
    #48357
    Purpose
    Targets beta-Tubulin for Cre-lox mediated knockout in T. brucei, Puromycin//Gancyclovir selectable
    Depositor
    Insert
    Partial beta-TUB followed by 5' ALD UTR-loxP-SAS-PUR-Ty1-TK-loxP-3' ALD UTR
    Use
    Cre/Lox; Knockout in t. brucei
    Available Since
    Jan. 17, 2014
    Availability
    Academic Institutions and Nonprofits only
  5. pAAV-Ef1a-DIO EYFP (AAV9)

    Viral Prep
    #27056-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-Ef1a-DIO EYFP (#27056). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO EYFP plasmid DNA. EF1a-driven, cre-dependent EYFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Tags
    EYFP (Cre-dependent)
    Available Since
    March 7, 2018
    Availability
    Academic Institutions and Nonprofits only
  6. pAAV-hSyn-DIO-mCherry (AAV1)

    Viral Prep
    #50459-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-hSyn-DIO-mCherry (#50459). In addition to the viral particles, you will also receive purified pAAV-hSyn-DIO-mCherry plasmid DNA. hSyn-driven, Cre-dependent mCherry-expression control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    mCherry (Cre-dependent)
    Available Since
    Feb. 3, 2020
    Availability
    Academic Institutions and Nonprofits only
  7. pAAV-Syn-FLEX-rc[ChrimsonR-tdTomato] (AAV5)

    Viral Prep
    #62723-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-Syn-FLEX-rc[ChrimsonR-tdTomato] (#62723). In addition to the viral particles, you will also receive purified pAAV-Syn-FLEX-rc[ChrimsonR-tdTomato] plasmid DNA. Cre-dependent ChrimsonR-tdTomato under the control of the Synapsin promoter. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    tdTomato (Cre-dependent)
    Available Since
    July 21, 2017
    Availability
    Academic Institutions and Nonprofits only
  8. pAAV_hSyn1-SIO-stGtACR2-FusionRed (AAV1)

    Viral Prep
    #105677-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_hSyn1-SIO-stGtACR2-FusionRed (#105677). In addition to the viral particles, you will also receive purified pAAV_hSyn1-SIO-stGtACR2-FusionRed plasmid DNA. Synapsin-driven, Cre-dependent, soma-targeted anion-conducting channelrhodopsin fused to FusionRed for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    FusionRed (Cre-dependent)
    Available Since
    Aug. 17, 2018
    Availability
    Academic Institutions and Nonprofits only
  9. pCAGGS-pac-T2A-iCre

    Plasmid
    #113849
    Purpose
    Puromycin resistance gene and iCre recombinase
    Depositor
    Insert
    pac-T2A-iCre
    Expression
    Mammalian
    Available Since
    Dec. 20, 2018
    Availability
    Academic Institutions and Nonprofits only
  10. pAAV-hSyn-DIO-EGFP (AAV5)

    Viral Prep
    #50457-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-hSyn-DIO-EGFP (#50457). In addition to the viral particles, you will also receive purified pAAV-hSyn-DIO-EGFP plasmid DNA. hSyn-driven, Cre-dependent EGFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    EGFP (Cre-dependent)
    Available Since
    July 8, 2019
    Availability
    Academic Institutions and Nonprofits only
  11. pAAV.Syn.Flex.GCaMP6s.WPRE.SV40 (AAV1)

    Viral Prep
    #100845-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV.Syn.Flex.GCaMP6s.WPRE.SV40 (#100845). In addition to the viral particles, you will also receive purified pAAV.Syn.Flex.GCaMP6s.WPRE.SV40 plasmid DNA. Syn-driven, Cre-dependent GCaMP6s calcium sensor. These AAV preparations are suitable purity for injection into animals.
    Promoter
    Syn
    Available Since
    May 11, 2018
    Availability
    Academic Institutions and Nonprofits only
  12. pRubiG-T2A-AKT3(S472A)-T2A-Cre

    Plasmid
    #189009
    Purpose
    Retroviral vector with a ubiquitin promoter expressing GFP, human AKT3 transcript variant 1 ORF with a phosphodeficient mutation at Serine 472, and Cre recombinase, separated by T2A motifs.
    Depositor
    Insert
    AKT3 (AKT3 Human)
    Use
    Retroviral
    Mutation
    Serine at 472 mutated to Alanine
    Available Since
    March 2, 2026
    Availability
    Academic Institutions and Nonprofits only
Showing: 1021 - 1040 of 3492 results